# Yineng Pharmar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yineng-pharmar

- Industry: Pharmaceuticals
- Headquarters: Changsha, China
- Website: www.ynswyy.cn
- Total disclosed funding: $15M
- Latest round: Series A (Mar 30, 2023)
- Investors on record: 2

## About

Founded in 2009 and based in Changsha, China, Yineng Pharmar is a a pharmaceutical company that focuses on the research and development of new traditional Chinese medicines and natural medicines. In 2016, the company built a new drug development platform for anti-infective small molecules. In 2021, it established a subsidiary Hunan Yunyao Zhiyan Information Technology Co., Ltd. In March 2023, Yineng Pharmar raised over CNY 100 million in series A funding led by new investor Guangdong Kaiheng Private Equity Investment Fund Management. Other new investor Huaige Capital also participated in the round.

The company has a database of Chinese medicinal materials, a database of formula and efficacy, a database of network pharmacology, a research platform for quality standards of medicinal materials and a research platform for traditional Chinese medicine processing. It provides traditional Chinese medicine drugs and drug research and development technical services.

## Funding rounds

- Series A, Mar 30, 2023, $15M — Huaige Capital, Kaiheng Capital

## Investors

- Huaige Capital (https://capitalatlas.ai/funds/huaige-capital) — Series A
- Kaiheng Capital (https://capitalatlas.ai/funds/kaiheng-capital) — Series A